Evaluation of FLEXOFYTOL® Versus PLACEBO
Launched by TILMAN S.A. · Sep 16, 2016
Trial Information
Current as of May 24, 2025
Completed
Keywords
ClinConnect Summary
150 patients suffering from symptomatic knee OA will be randomized in 3 parallel groups (50 patients per group). Each patient will be enrolled in the study for 6 months including 4 visits: Inclusion visit (T0), follow-up visits after 1 month (T1), 3 months (T3) and 6 months (T6).
A. Primary objective
- Evaluate the efficacy of two different dosages of FLEXOFYTOL® versus PLACEBO on arthritis related biomarker coll2-1 and on patient assessment of disease activity in patients suffering from knee OA after a 3 months treatment
B. Secondary objectives
* Evaluate the efficacy of two different ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female between the age of 45 and 80
- Exclusion Criteria:
- • Artialis (study coordinator) or Tilman (Sponsor) 's employees
- • Participation to a therapeutic clinical trial in the last 3 months
- • Under guardianship or judicial protection
About Tilman S.A.
Tilman S.A. is a leading pharmaceutical company dedicated to advancing healthcare through innovative research and development. Specializing in the formulation of high-quality medicinal products, Tilman S.A. focuses on addressing unmet medical needs across various therapeutic areas, including pain management, respiratory health, and nutritional support. With a commitment to scientific excellence and patient welfare, the company actively engages in clinical trials to evaluate the safety and efficacy of its products, collaborating with healthcare professionals and institutions to ensure rigorous adherence to regulatory standards. Tilman S.A. strives to enhance patient outcomes and contribute to the global healthcare community through its ongoing dedication to innovation and quality.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liège, Province Of Liege, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials